Literature DB >> 27626515

Clinical Trials, Healthy Controls, and the Birth of the IRB.

Laura Stark1, Jeremy A Greene1.   

Abstract

Mesh:

Year:  2016        PMID: 27626515     DOI: 10.1056/NEJMp1607653

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  A call for improved transparency in financial aspects of clinical trials: a case study of the CREATE-X trial in the New England Journal of Medicine.

Authors:  Akihiko Ozaki; Morihito Takita; Tetsuya Tanimoto
Journal:  Invest New Drugs       Date:  2018-03-08       Impact factor: 3.850

2.  Prognostic Enrichment Design in Clinical Trials for Autosomal Dominant Polycystic Kidney Disease.

Authors:  Theodore Steinman
Journal:  Kidney Int Rep       Date:  2016-10-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.